Dolby Laboratories, Inc. (NYSE:DLB) Stock Holdings Lowered by Stephens Inc. AR

Stephens Inc. AR trimmed its holdings in shares of Dolby Laboratories, Inc. (NYSE:DLBFree Report) by 13.5% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,734 shares of the electronics maker’s stock after selling 426 shares during the period. Stephens Inc. AR’s holdings in Dolby Laboratories were worth $214,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. CWM LLC grew its holdings in shares of Dolby Laboratories by 27.9% in the 3rd quarter. CWM LLC now owns 3,978 shares of the electronics maker’s stock worth $304,000 after acquiring an additional 868 shares during the last quarter. Creative Planning boosted its position in shares of Dolby Laboratories by 7.5% in the 3rd quarter. Creative Planning now owns 4,094 shares of the electronics maker’s stock valued at $313,000 after purchasing an additional 286 shares during the period. Net Worth Advisory Group purchased a new position in Dolby Laboratories in the 3rd quarter worth about $260,000. Blue Trust Inc. raised its holdings in Dolby Laboratories by 234.3% during the 3rd quarter. Blue Trust Inc. now owns 1,384 shares of the electronics maker’s stock worth $110,000 after buying an additional 970 shares during the period. Finally, International Assets Investment Management LLC purchased a new stake in Dolby Laboratories during the third quarter valued at about $3,895,000. Institutional investors and hedge funds own 58.56% of the company’s stock.

Dolby Laboratories Price Performance

Shares of DLB opened at $83.72 on Monday. The company has a market capitalization of $7.99 billion, a price-to-earnings ratio of 30.78 and a beta of 0.98. The business’s 50-day moving average is $80.26 and its 200-day moving average is $76.06. Dolby Laboratories, Inc. has a fifty-two week low of $66.35 and a fifty-two week high of $89.66.

Dolby Laboratories Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, February 19th. Shareholders of record on Tuesday, February 11th will be paid a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.58%. The ex-dividend date is Tuesday, February 11th. Dolby Laboratories’s dividend payout ratio (DPR) is currently 48.53%.

Analyst Ratings Changes

Several research firms have recently weighed in on DLB. StockNews.com downgraded shares of Dolby Laboratories from a “strong-buy” rating to a “buy” rating in a research report on Friday, January 31st. Rosenblatt Securities reissued a “buy” rating and set a $100.00 target price on shares of Dolby Laboratories in a research note on Thursday, January 30th. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $100.00 target price on shares of Dolby Laboratories in a research report on Thursday.

Check Out Our Latest Analysis on DLB

Insider Activity

In other news, Director Peter C. Gotcher sold 6,079 shares of Dolby Laboratories stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $78.96, for a total transaction of $479,997.84. Following the completion of the sale, the director now directly owns 37,593 shares in the company, valued at $2,968,343.28. The trade was a 13.92 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Ryan Nicholson sold 7,000 shares of the business’s stock in a transaction that occurred on Wednesday, February 5th. The shares were sold at an average price of $84.07, for a total value of $588,490.00. Following the completion of the sale, the chief accounting officer now directly owns 29,758 shares of the company’s stock, valued at approximately $2,501,755.06. The trade was a 19.04 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 182,917 shares of company stock worth $14,861,429 in the last ninety days. Corporate insiders own 38.39% of the company’s stock.

Dolby Laboratories Profile

(Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Featured Stories

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories, Inc. (NYSE:DLBFree Report).

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.